ASLAN Pharmaceuticals (NASDAQ: ASLN )  -50%  on pricing equity offering. More news on: ASLAN Pharmaceuticals Limited, CBL & Associates Properties, Inc, Aldeyra Therapeutics, Inc., Stocks on the move, Read more ...

Thinly traded micro cap Aldeyra Therapeutics (NASDAQ: ALDX ) slumps  27%  premarket on increased volume in response to results from the first phase of a two-part Phase 3 clinical trial, RENEW , evaluating topical ophthalmic solution reproxalap, an aldehyde trap,  in patient...

Primary objective of RENEW Part 1 achieved: Induction-maintenance dosing regimen of topical ocular reproxalap advanced to RENEW Part 2 Reproxalap statistically superior to vehicle in RENEW co-primary endpoint of ocular dryness score in induction-maintenance regimen - symptomatic imp...